TTY Biopharm Co Ltd - Asset Resilience Ratio

Latest as of March 2026: 4.36%

TTY Biopharm Co Ltd (4105) has an Asset Resilience Ratio of 4.36% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See working capital to net assets of TTY Biopharm Co Ltd to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

NT$509.60 Million

≈ $16.06 Million USD Cash + Short-term Investments

Total Assets

NT$11.68 Billion

≈ $367.85 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2017–2025)

This chart shows how TTY Biopharm Co Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see how large is TTY Biopharm Co Ltd's balance sheet.

Liquid Assets Composition Over Time

This chart breaks down TTY Biopharm Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read 4105 total liabilities for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	NT$0.00	0%
Short-term Investments	NT$509.60 Million	4.36%
Total Liquid Assets	NT$509.60 Million	4.36%

Asset Resilience Insights

Limited Liquidity: TTY Biopharm Co Ltd maintains only 4.36% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

TTY Biopharm Co Ltd Industry Peers by Asset Resilience Ratio

Compare TTY Biopharm Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Torrent Pharmaceuticals Limited NSE:TORNTPHARM	Drug Manufacturers - Specialty & Generic	2.79%
Swedish Orphan Biovitrum AB (publ) ST:SOBI	Drug Manufacturers - Specialty & Generic	1.54%
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt F:RIG2	Drug Manufacturers - Specialty & Generic	0.20%
Beijing Tongrentang Co Ltd SHG:600085	Drug Manufacturers - Specialty & Generic	2.51%
Shandong Buchang Pharmaceuticals Co Ltd SHG:603858	Drug Manufacturers - Specialty & Generic	3.47%
Shan Dong Dong-E E-Jiao Co Ltd SHE:000423	Drug Manufacturers - Specialty & Generic	20.44%
Harbin Pharmaceutical Group Co Ltd SHG:600664	Drug Manufacturers - Specialty & Generic	0.97%
Kangmei Pharmaceutical Co Ltd SHG:600518	Drug Manufacturers - Specialty & Generic	0.00%

Annual Asset Resilience Ratio for TTY Biopharm Co Ltd (2017–2025)

The table below shows the annual Asset Resilience Ratio data for TTY Biopharm Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	4.12%	NT$467.74 Million ≈ $14.74 Million	NT$11.35 Billion ≈ $357.53 Million	+1.28pp
2024-12-31	2.84%	NT$309.01 Million ≈ $9.74 Million	NT$10.86 Billion ≈ $342.24 Million	+0.86pp
2023-12-31	1.98%	NT$195.54 Million ≈ $6.16 Million	NT$9.87 Billion ≈ $311.11 Million	-1.42pp
2022-12-31	3.40%	NT$326.86 Million ≈ $10.30 Million	NT$9.60 Billion ≈ $302.47 Million	-0.60pp
2021-12-31	4.01%	NT$372.65 Million ≈ $11.74 Million	NT$9.30 Billion ≈ $292.89 Million	+0.35pp
2020-12-31	3.66%	NT$342.40 Million ≈ $10.79 Million	NT$9.36 Billion ≈ $294.92 Million	-1.39pp
2019-12-31	5.05%	NT$482.62 Million ≈ $15.21 Million	NT$9.55 Billion ≈ $300.96 Million	-0.81pp
2018-12-31	5.86%	NT$530.83 Million ≈ $16.72 Million	NT$9.05 Billion ≈ $285.22 Million	-12.77pp
2017-12-31	18.64%	NT$1.77 Billion ≈ $55.82 Million	NT$9.51 Billion ≈ $299.52 Million	--

pp = percentage points

About TTY Biopharm Co Ltd

TWO:4105 Taiwan Drug Manufacturers - Specialty & Generic

Market Cap

$618.87 Million

NT$19.64 Billion TWD

Market Cap Rank

#11322 Global

#402 in Taiwan

Share Price

NT$79.00

Change (1 day)

-0.13%

52-Week Range

NT$72.10 - NT$86.30

All Time High

NT$97.91